Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Lifevantage Corporation (LXRX)

« Back to company index

LXRX Chatter Timeline

Stock Ticker for LXRX

Most Active Tweeters for LXRX

UserTweets
@Tickeron 11
@dispatchtribune 5
@ConsumerFeed 4
@WatchlistN 4
@AmericanBanking 3

Recent Tweets for LXRX

otcdynamics @otcdynamics
$LXRX Lexicon Pharmaceuticals Announces Poster Presentation at the ASCO 2020 Gastrointestinal Cancers Symposium https://t.co/apewDPSZ73
4:01pm
newsfilterio @newsfilterio
Lexicon Pharmaceuticals Announces Poster Presentation at the ASCO 2020 Gastrointestinal Cancers Symposium $LXRX https://t.co/TZEJSoCEKa
4:01pm
Tickeron @Tickeron
$LXRX's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/34RCIpYTRL
January 19th 2020, 10:01pm
gcassidy718 @gcassidy718
$LXRX Hoping to exit this position at some point . . . -4.72 % change recently https://t.co/GvztssB0iO
January 19th 2020, 8:01pm
gcassidy718 @gcassidy718
$LXRX significant stock price movement -4.72 % change recently https://t.co/GvztssB0iO
January 18th 2020, 10:01pm
TranscriptDaily @TranscriptDaily
-$0.76 EPS Expected for Lexicon Pharmaceuticals, Inc. $LXRX This Quarter https://t.co/ckPnAuaqbt
January 18th 2020, 8:01pm
newsfilterio @newsfilterio
Lexicon Pharmaceuticals Expected to Announce Earnings of -$0.76 Per Share $LXRX https://t.co/fGwlj0DOu3
January 18th 2020, 8:01pm
stocknewstimes @stocknewstimes
Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Earnings of -$0.76 Per Share https://t.co/FZcuat0HcN
January 18th 2020, 8:01pm
TranscriptDaily @TranscriptDaily
Lexicon Pharmaceuticals $LXRX Downgraded by Zacks Investment Research https://t.co/hRXIE6K3hi
January 18th 2020, 10:01am
Tickeron @Tickeron
$LXRX's price moved above its 50-day Moving Average on January 13, 2020. View odds for this and other indicators:… https://t.co/xiYJ8nWDvP
January 17th 2020, 11:01pm
BlueBioNow @BlueBioNow
$LXRX What happened??? why the bounce?? -4.60 % change recently https://t.co/e90khvbZCK
January 17th 2020, 6:01pm
Tickeron @Tickeron
$LXRX's price moved above its 50-day Moving Average on January 13, 2020. View odds for this and other indicators:… https://t.co/OQ7SqjL8wt
January 16th 2020, 11:01pm
fintel_io @fintel_io
$LXRX / Lexicon Pharmaceuticals files form 8-K - Entry into a Material Definitive Agreement, Financial Statements a… https://t.co/yjA0GgaGyz
January 16th 2020, 4:01pm
StockTexts @StockTexts
$LXRX Lexicon Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/y5J9l2bIIs
January 16th 2020, 4:01pm
OlympiaReport @OlympiaReport
Lexicon Pharmaceuticals, Inc. $LXRX Expected to Post Quarterly Sales of $10.59 Million https://t.co/5frfm7GmuB
January 16th 2020, 1:01pm
WatchlistN @WatchlistN
-$0.76 EPS Expected for Lexicon Pharmaceuticals, Inc. $LXRX This Quarter https://t.co/Q8bCATPhpx
January 16th 2020, 1:01pm
dispatchtribune @dispatchtribune
Lexicon Pharmaceuticals, Inc. $LXRX Expected to Post Earnings of -$0.76 Per Share https://t.co/ec0aNjN2Mv
January 16th 2020, 1:01pm
WeekHerald @WeekHerald
Lexicon Pharmaceuticals, Inc. $LXRX Expected to Post Quarterly Sales of $10.59 Million https://t.co/rf7BDaEtiG
January 16th 2020, 12:01pm
dailypoliticaln @dailypoliticaln
Lexicon Pharmaceuticals $LXRX Rating Lowered to Hold at Zacks Investment Research https://t.co/G7nOU4dM4X
January 16th 2020, 12:01pm
ConsumerFeed @ConsumerFeed
Lexicon Pharmaceuticals $LXRX Stock Rating Lowered by Zacks Investment Research https://t.co/Rcbks3c7iT
January 16th 2020, 12:01pm
Easy_Money_weee @Easy_Money_weee
$LXRX and $FCEL nice day so far.
January 16th 2020, 9:01am
TheMarketsDaily @TheMarketsDaily
Lexicon Pharmaceuticals, Inc. $LXRX Short Interest Update https://t.co/mlQCFcttHE
January 15th 2020, 7:01pm
stocknewstimes @stocknewstimes
Lexicon Pharmaceuticals, Inc. $LXRX Short Interest Update https://t.co/UONX7Hwxdk
January 15th 2020, 7:01pm
gcassidy718 @gcassidy718
$LXRX "Everything is impossible until someone does it" 2.76 % change recently https://t.co/GvztssB0iO
January 15th 2020, 7:01pm
dispatchtribune @dispatchtribune
Lexicon Pharmaceuticals $LXRX Downgraded to “Hold” at Zacks Investment Research https://t.co/PYhpg8hRZT
January 15th 2020, 5:01pm
WatchlistN @WatchlistN
Lexicon Pharmaceuticals $LXRX Downgraded to “Hold” at Zacks Investment Research https://t.co/D0zYZS7MKh
January 15th 2020, 5:01pm
WatchlistN @WatchlistN
Short Interest in Lexicon Pharmaceuticals, Inc. $LXRX Grows By 17.8% https://t.co/L0t1vIPaHT
January 15th 2020, 3:01pm
OlympiaReport @OlympiaReport
Short Interest in Lexicon Pharmaceuticals, Inc. $LXRX Grows By 17.8% https://t.co/6SPBx23nLQ
January 15th 2020, 3:01pm
SerialTrader72 @SerialTrader72
$LXRX could fly very soon ???
January 15th 2020, 11:01am
BlueBioNow @BlueBioNow
$LXRX was oversold imo -4.79 % https://t.co/e90khvbZCK
January 15th 2020, 7:01am
WatchlistN @WatchlistN
Lexicon Pharmaceuticals $LXRX Stock Rating Upgraded by Zacks Investment Research https://t.co/HYgKYrhhrq
January 15th 2020, 4:01am
ConsumerFeed @ConsumerFeed
Lexicon Pharmaceuticals $LXRX Stock Rating Upgraded by Zacks Investment Research https://t.co/ctpALUzuwP
January 15th 2020, 4:01am
StockConsultant @StockConsultant
$LXRX Lexicon Pharmaceuticals stock watch, attempting to move higher off 4.18 support area #investing101 #stockpicks https://t.co/dWpvkEsVz1
January 14th 2020, 8:01am
TickerReport @TickerReport
Brokerages Expect Lexicon Pharmaceuticals, Inc. $LXRX Will Announce Earnings of -$0.76 Per Share https://t.co/wCDjcMHHvp
January 14th 2020, 6:01am
ThisLincolnian @ThisLincolnian
Zacks: Brokerages Expect Lexicon Pharmaceuticals, Inc. $LXRX Will Post Earnings of -$0.76 Per Share https://t.co/nUzCR8XY3V
January 14th 2020, 6:01am
EnterpriseLeade @EnterpriseLeade
Lexicon Pharmaceuticals $LXRX Rating Increased to Buy at Zacks Investment Research https://t.co/h5l2ZHPABi
January 14th 2020, 3:01am
EnterpriseLeade @EnterpriseLeade
Lexicon Pharmaceuticals $LXRX Lowered to “Hold” at Zacks Investment Research https://t.co/mRU0b3HlMH
January 14th 2020, 3:01am
Tickeron @Tickeron
$LXRX in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators:… https://t.co/op2UvFKILm
January 13th 2020, 11:01pm
dailypoliticaln @dailypoliticaln
Lexicon Pharmaceuticals $LXRX Trading 6.2% Higher https://t.co/rhcB3oqamT
January 13th 2020, 11:01pm
AmericanBanking @AmericanBanking
Short Interest in Lexicon Pharmaceuticals, Inc. $LXRX Rises By 17.8% https://t.co/SkAnX3vbfp #stocks
January 13th 2020, 9:01am
bbnsnews @bbnsnews
Short Interest in Lexicon Pharmaceuticals, Inc. $LXRX Rises By 17.8% https://t.co/SlrIoyK0Eh
January 13th 2020, 9:01am
dispatchtribune @dispatchtribune
Short Interest in Lexicon Pharmaceuticals, Inc. $LXRX Rises By 17.8% https://t.co/ph2YKZpwrG
January 13th 2020, 9:01am
bbnsnews @bbnsnews
Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Quarterly Sales of $10.59 Million https://t.co/k9JyVGIAhG
January 13th 2020, 3:01am
ZolmaxNews @ZolmaxNews
Lexicon Pharmaceuticals, Inc. $LXRX Expected to Post Quarterly Sales of $10.59 Million https://t.co/5I7DhJ2iMe
January 13th 2020, 3:01am
AmericanBanking @AmericanBanking
Lexicon Pharmaceuticals, Inc. $LXRX Expected to Post Quarterly Sales of $10.59 Million https://t.co/9U8clIoCHR #stocks
January 13th 2020, 3:01am
TickerReport @TickerReport
Lexicon Pharmaceuticals $LXRX Rating Increased to Buy at Zacks Investment Research https://t.co/Z1Yujo9UuC
January 13th 2020, 2:01am
ZolmaxNews @ZolmaxNews
Lexicon Pharmaceuticals $LXRX Upgraded to Buy at Zacks Investment Research https://t.co/AdIhMFrZ5p
January 13th 2020, 2:01am
Tickeron @Tickeron
$LXRX in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators:… https://t.co/bnfzOZsyYY
January 13th 2020, 12:01am
newsfilterio @newsfilterio
Lexicon Pharmaceuticals Upgraded to Buy by Zacks Investment Research $LXRX https://t.co/vy0FhGaR5S
January 12th 2020, 1:01pm
TheMarketsDaily @TheMarketsDaily
Lexicon Pharmaceuticals $LXRX Upgraded to Buy by Zacks Investment Research https://t.co/ShW7N3SWw8
January 12th 2020, 1:01pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.